Dr. Thomas L Waltemate, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 403 S Charles, Steeleville, IL 62288 Phone: 618-965-9213 Fax: 618-965-9213 |
News Archive
The ovarian cancer market is highly active with several promising candidates having reached the late stages of development. Three PARP inhibitors, Lynparza (AstraZeneca), niraparib (Tesaro) and rucaparib (Clovis Oncology), which induce cell death in mutated [BRCA-deficient] cancer cells, have been identified by Datamonitor Healthcare as front runners.
The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).
One survey reveals that doctors fear some of the changes due to the health law, while primary care physicians say the law may spur needed change.
Excessive consumption of fructose -; a sweetener ubiquitous in the American diet -; can result in non-alcoholic fatty liver disease (NAFLD), which is comparably abundant in the United States.
Asian-Americans not only have a desire to care for aging relatives themselves, but it is part of their common cultural practices and norms. As a result, Asian-American caregivers experience a greater demand for family caregiving than other cultural and ethnic groups.
› Verified 9 days ago